Effects of Inhibiting Dipeptidyl Peptidase-4 (DPP4) in Cows with Subclinical Ketosis.

Effects of Inhibiting Dipeptidyl Peptidase-4 (DPP4) in Cows with Subclinical Ketosis.

The inhibition of dipeptidyl peptidase-4 (DPP4) via specific inhibitors is known to result in improved glucose tolerance and insulin sensitivity and decreased accumulation of hepatic fat in type II diabetic human patients. The metabolic situation of dairy cows can easily be compared to the status of...

Full description

Bibliographic Details
Main Authors:	Kirsten Schulz, Jana Frahm, Susanne Kersten, Ulrich Meyer, Jürgen Rehage, Marion Piechotta, Maria Meyerholz, Gerhard Breves, Dania Reiche, Helga Sauerwein, Sven Dänicke
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4546328?pdf=render

Similar Items

DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS
by: Erna Kristin
Published: (2016-12-01)

The Expression and Role of Dipeptidyl- Peptidase-4 (DPP-4) in Insulin Resistance and Diabetes Mellitus
by: Stevenson, Claire Louise
Published: (2014)

Biochemical Characterization of Dipeptidyl Peptidase IV (DPP-IV) and DPP9
by: Hung-Kuan Tang, et al.
Published: (2009)

Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis
by: Jung Min Lee, et al.
Published: (2019-10-01)

A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4
by: Takehiro Yamaguchi, et al.
Published: (2019-02-01)

Effect of Dipeptidyl Peptidase IV (DPP-4) Inhibitor on the Cardiovascular and Kidney Ultrastructure of the Hyperglycemic Rats
by: Wan-Ru Wang, et al.
Published: (2014)

Combination treatment for type 2 diabetes mellitus (T2DM) : dipeptidyl peptidase-4 inhibitors (DPP-4) and metformin
by: Erna Kristin
Published: (2017-10-01)

Reduced humidity induces skin barrier dysfunction and secretion of dipeptidyl peptidase-4 (DPP-4) in a skin-equivalent model
by: Lee Sung Hoon, et al.
Published: (2019-01-01)

Identification of Dipeptidyl-Peptidase (DPP)5 and DPP7 in Porphyromonas endodontalis, Distinct from Those in Porphyromonas gingivalis.
by: Haruka Nishimata, et al.
Published: (2014-01-01)

Clinical Features and Outcomes of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid (DPP4i-Associated BP) in Thai Patients
by: Yotsapon Thewjitcharoen, et al.
Published: (2020-01-01)

Increased Plasma Dipeptidyl Peptidase-4 (DPP4) Activity Is an Obesity-Independent Parameter for Glycemic Deregulation in Type 2 Diabetes Patients
by: Jit Sarkar, et al.
Published: (2019-07-01)

Inhibition of dipeptidyl peptidase IV (DPP-IV) by proline containing casein-derived peptides
by: Alice B. Nongonierma, et al.
Published: (2013-10-01)

Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
by: A S Ametov, et al.
Published: (2013-01-01)

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
by: Na-Hyung Kim, et al.
Published: (2014-01-01)

Investigation the possible connection between dipeptidyl-peptidase (DPP)-4 inhibitors and the development of acute pancreatitis in type II diabetic patients
by: WU, SHIH-HUI, et al.
Published: (2017)

Comparative Binding Analysis of Dipeptidyl Peptidase IV (DPP-4) with Antidiabetic Drugs - An Ab Initio Fragment Molecular Orbital Study.
by: Sundaram Arulmozhiraja, et al.
Published: (2016-01-01)

Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach
by: Isabelle M.E. Lacroix, et al.
Published: (2012-04-01)

Dipeptidyl peptidase 4 inhibitors in modern domestic practice
by: A. S. Ametov, et al.
Published: (2020-05-01)

Dipeptidyl peptidase-4 inhibitors use in clinical practice
by: Tatiana B. Morgunova, et al.
Published: (2019-04-01)

Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism
by: Natasha A Trzaskalski, et al.
Published: (2020-03-01)

Navigating the chemical space of dipeptidyl peptidase-4 inhibitors
by: Shoombuatong W, et al.
Published: (2015-08-01)

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
by: Kaisa Tasanen, et al.
Published: (2019-06-01)

Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose
by: Das SS, et al.
Published: (2014-05-01)

Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions
by: Awadhesh Kumar Singh
Published: (2014-01-01)

Health economic evaluation of dipeptidyl peptidase-4 inhibitors
by: Vishvas Garg
Published: (2011-01-01)

Elevated Dipeptidyl Peptidase IV (DPP-IV) Activity in Plasma from Patients with Various Lysosomal Diseases
by: Agnieszka Ługowska, et al.
Published: (2021-02-01)

Rapid Identification of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides from Ruditapes philippinarum Hydrolysate
by: Rui Liu, et al.
Published: (2017-10-01)

Chromogenic detection of dipeptidyl peptidase IV (DPP-IV) activity using peptide-functionalized gold nanoparticles
by: Aldewachi, Hasan
Published: (2017)

Dipeptidyl peptidase IV (DPP-IV) inhibitory properties of camel milk protein hydrolysates generated with trypsin
by: Alice B. Nongonierma, et al.
Published: (2017-07-01)

Impact on decision making framework for medicine purchasing in Chinese public hospital decision-making: determining the value of five dipeptidyl peptidase 4 (DPP-4) inhibitors
by: Yun Bao, et al.
Published: (2021-08-01)

α-Amylase and dipeptidyl peptidase-4 (DPP-4) inhibitory effects of Melicope latifolia bark extracts and identification of bioactive constituents using in vitro and in silico approaches
by: Alexandra Quek, et al.
Published: (2021-01-01)

Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis
by: Dan Liu, et al.
Published: (2019-03-01)

Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging
by: Fen Cao, et al.
Published: (2021-08-01)

Development of a fluorogenic small substrate for dipeptidyl peptidase-4
by: Futa Ogawa, et al.
Published: (2017-12-01)

Dipeptidyl Peptidase-4 and Adolescent Idiopathic Scoliosis: Expression in Osteoblasts
by: Emilie Normand, et al.
Published: (2017-06-01)

The role of dipeptidyl peptidase - 4 inhibitors in diabetic kidney disease
by: Usha ePanchapakesan, et al.
Published: (2015-08-01)

Involvement of dipeptidyl peptidase 4 in extravillous trophoblast invasion and differentiation
by: Sato, Yukiyasu
Published: (2011)

Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation
by: Harika Meduru, et al.
Published: (2016-06-01)

Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice
by: Annayya R. Aroor, et al.
Published: (2017-05-01)

Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway
by: Xin Wang, et al.
Published: (2021-09-01)